Ibotta (IBTA) Competitors $36.47 +0.71 (+1.99%) As of 07/3/2025 03:30 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IBTA vs. HNGE, TNET, CARG, CNXC, PAGS, DLO, ATHM, ALIT, FA, and CLVTShould you be buying Ibotta stock or one of its competitors? The main competitors of Ibotta include Hinge Health (HNGE), TriNet Group (TNET), CarGurus (CARG), Concentrix (CNXC), PagSeguro Digital (PAGS), DLocal (DLO), Autohome (ATHM), Alight (ALIT), First Advantage (FA), and Clarivate (CLVT). These companies are all part of the "business services" industry. Ibotta vs. Its Competitors Hinge Health TriNet Group CarGurus Concentrix PagSeguro Digital DLocal Autohome Alight First Advantage Clarivate Ibotta (NYSE:IBTA) and Hinge Health (NYSE:HNGE) are both business services companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability, media sentiment and analyst recommendations. Is IBTA or HNGE more profitable? Ibotta has a net margin of 16.24% compared to Hinge Health's net margin of 0.00%. Ibotta's return on equity of 15.04% beat Hinge Health's return on equity.Company Net Margins Return on Equity Return on Assets Ibotta16.24% 15.04% 9.71% Hinge Health N/A N/A N/A Do analysts recommend IBTA or HNGE? Ibotta presently has a consensus price target of $61.60, suggesting a potential upside of 68.91%. Hinge Health has a consensus price target of $46.00, suggesting a potential downside of 1.35%. Given Ibotta's higher possible upside, analysts plainly believe Ibotta is more favorable than Hinge Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ibotta 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83Hinge Health 0 Sell rating(s) 0 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better valuation & earnings, IBTA or HNGE? Ibotta has higher revenue and earnings than Hinge Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIbotta$367.25M2.51$68.74M$1.4824.64Hinge HealthN/AN/AN/AN/AN/A Does the media prefer IBTA or HNGE? In the previous week, Ibotta had 5 more articles in the media than Hinge Health. MarketBeat recorded 8 mentions for Ibotta and 3 mentions for Hinge Health. Ibotta's average media sentiment score of 0.57 beat Hinge Health's score of 0.21 indicating that Ibotta is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ibotta 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hinge Health 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryIbotta beats Hinge Health on 7 of the 9 factors compared between the two stocks. Get Ibotta News Delivered to You Automatically Sign up to receive the latest news and ratings for IBTA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IBTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IBTA vs. The Competition Export to ExcelMetricIbottaTechnology Services IndustryBusiness SectorNYSE ExchangeMarket Cap$905.10M$2.37B$12.98B$20.55BDividend YieldN/A1.34%2.57%3.75%P/E Ratio24.6431.4428.6628.05Price / Sales2.5136.3242.4145.92Price / Cash14.2140.7025.6822.31Price / Book2.475.876.274.59Net Income$68.74M$32.32M$187.50M$985.44M7 Day Performance-0.98%5.99%3.54%2.78%1 Month Performance-24.65%7.19%4.13%5.40%1 Year PerformanceN/A32.79%27.93%14.61% Ibotta Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IBTAIbotta3.2706 of 5 stars$36.47+2.0%$61.60+68.9%N/A$905.10M$367.25M24.64N/AHNGEHinge HealthN/A$46.87+7.3%$46.00-1.9%N/A$3.66BN/A0.001,514Quiet Period ExpirationHigh Trading VolumeTNETTriNet Group3.9499 of 5 stars$75.00+0.7%$96.67+28.9%-25.1%$3.63B$5.05B22.393,600Positive NewsEx-DividendCARGCarGurus4.5039 of 5 stars$33.31+2.4%$36.95+10.9%+38.4%$3.48B$894.38M95.171,282Trending NewsAnalyst DowngradeInsider TradeCNXCConcentrix4.6889 of 5 stars$54.08+4.5%$67.25+24.4%-14.4%$3.45B$9.59B13.55450,000PAGSPagSeguro Digital3.5822 of 5 stars$9.96+10.1%$11.63+16.8%-21.2%$3.28B$3.22B8.168,595DLODLocal1.7132 of 5 stars$11.16+8.8%$12.45+11.6%+43.6%$3.19B$745.97M22.781,095High Trading VolumeATHMAutohome3.3273 of 5 stars$26.06+2.5%$32.00+22.8%-4.9%$3.12B$964.42M14.404,415ALITAlight4.4759 of 5 stars$5.52+2.5%$9.81+77.9%-15.8%$2.97B$2.32B-39.399,500News CoverageOptions VolumeFAFirst Advantage2.6233 of 5 stars$16.80+0.3%$66.00+292.9%+6.3%$2.92B$1.05B560.005,500Positive NewsCLVTClarivate1.9534 of 5 stars$4.08+2.4%$5.00+22.7%-22.3%$2.78B$2.53B-4.2012,000Insider TradeHigh Trading Volume Related Companies and Tools Related Companies Hinge Health Competitors TriNet Group Competitors CarGurus Competitors Concentrix Competitors PagSeguro Digital Competitors DLocal Competitors Autohome Competitors Alight Competitors First Advantage Competitors Clarivate Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:IBTA) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ibotta, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ibotta With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
